Research Article
A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas
Figure 5
The impact of CLEC4GP1 and ZNF767P on TMZ resistance and relevant molecular alterations in GBM cells. IC50 of (a) DBTRG-05MG cells with siRNA knockdown of ZNF767P under the treatment of TMZ; IC50 of (b) DBTRG-05MG and (c) U251 cells with siRNA knockdown of CLEC4GP1 under the treatment of TMZ; and (d) protein levels of key components in different DNA repair pathways in DBTRG-05MG cells with siRNA knockdown of CLEC4GP1 and ZNF767P, respectively; ; ; .
(a) |
(b) |
(c) |
(d) |